277 related articles for article (PubMed ID: 28431273)
1. Chromosomal Instability in Gastric Cancer Biology.
Maleki SS; Röcken C
Neoplasia; 2017 May; 19(5):412-420. PubMed ID: 28431273
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization.
Mathiak M; Warneke VS; Behrens HM; Haag J; Böger C; Krüger S; Röcken C
Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):12-24. PubMed ID: 26371427
[TBL] [Abstract][Full Text] [Related]
3. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
[TBL] [Abstract][Full Text] [Related]
4. Molecular classification of gastric cancer.
Röcken C
Expert Rev Mol Diagn; 2017 Mar; 17(3):293-301. PubMed ID: 28118758
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy.
Nemtsova MV; Kuznetsova EB; Bure IV
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069284
[TBL] [Abstract][Full Text] [Related]
6. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C
Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival.
Grogg KL; Lohse CM; Pankratz VS; Halling KC; Smyrk TC
Mod Pathol; 2003 Jul; 16(7):641-51. PubMed ID: 12861059
[TBL] [Abstract][Full Text] [Related]
8. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
Lim B; Kim JH; Kim M; Kim SY
World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657
[TBL] [Abstract][Full Text] [Related]
9. Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade.
Toshima T; Tanioka H; Mori Y; Tanaka T; Yasui K; Kimura K; Umeda Y; Fujiwara T; Nyuya A; Yano S; Nagasaka T
Oncology; 2023; 101(2):105-116. PubMed ID: 36244328
[TBL] [Abstract][Full Text] [Related]
10. [Gastric tumors and tumor precursors].
Röcken C
Pathologe; 2017 Mar; 38(2):75-86. PubMed ID: 28084526
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.
Carrascal E; Koriyama C; Akiba S; Tamayo O; Itoh T; Eizuru Y; Garcia F; Sera M; Carrasquilla G; Piazuelo MB; Florez L; Bravo JC
Oncol Rep; 2003; 10(4):1059-62. PubMed ID: 12792770
[TBL] [Abstract][Full Text] [Related]
12. Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm.
Park CK; Park JS; Kim HS; Rha SY; Hyung WJ; Cheong JH; Noh SH; Lee SK; Lee YC; Huh YM; Kim H
Oncotarget; 2016 Nov; 7(44):72099-72112. PubMed ID: 27765925
[TBL] [Abstract][Full Text] [Related]
13. DNA Methylation and Genetic Aberrations in Gastric Cancer.
Usui G; Matsusaka K; Mano Y; Urabe M; Funata S; Fukayama M; Ushiku T; Kaneda A
Digestion; 2021; 102(1):25-32. PubMed ID: 33070127
[TBL] [Abstract][Full Text] [Related]
14. Patterns of genomic instability in gastric cancer: clinical implications and perspectives.
Ottini L; Falchetti M; Lupi R; Rizzolo P; Agnese V; Colucci G; Bazan V; Russo A
Ann Oncol; 2006 Jun; 17 Suppl 7():vii97-102. PubMed ID: 16760303
[TBL] [Abstract][Full Text] [Related]
15. Alteration in stemness causes exclusivity between Epstein-Barr virus-positivity and microsatellite instability status in gastric cancer.
Kim Y; Shin YJ; Wen X; Cho NY; Li M; Kim YJ; Song SH; Kang GH
Gastric Cancer; 2021 May; 24(3):602-610. PubMed ID: 33386473
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Gonzalez RS; Messing S; Tu X; McMahon LA; Whitney-Miller CL
Hum Pathol; 2016 Oct; 56():16-21. PubMed ID: 27342907
[TBL] [Abstract][Full Text] [Related]
17. Emerging molecular classifications and therapeutic implications for gastric cancer.
Chen T; Xu XY; Zhou PH
Chin J Cancer; 2016 May; 35():49. PubMed ID: 27233623
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis.
Betge J; Pollheimer MJ; Schlemmer A; Hoefler G; Langner C
Oncol Rep; 2011 Sep; 26(3):567-75. PubMed ID: 21687951
[TBL] [Abstract][Full Text] [Related]
19. Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
Silva ANS; Saito Y; Yoshikawa T; Oshima T; Hayden JD; Oosting J; Earle S; Hewitt LC; Slaney HL; Wright A; Inam I; Langley RE; Allum W; Nankivell MG; Hutchins G; Cunningham D; Grabsch HI
Br J Surg; 2022 Feb; 109(3):291-297. PubMed ID: 35179206
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy.
Kim HS; Shin SJ; Beom SH; Jung M; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Noh SH; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Koom WS; Lim JS; Chung HC; Rha SY; Kim H
Oncotarget; 2016 Jul; 7(28):44608-44620. PubMed ID: 27331626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
